NGS EQA 2025

1. different EQA subschemes for mutation analyses: 

   • A. targeted multi marker NGS panels basic: therapy-relevant genes across entities 
   • B. NSCLC- specific NGS panels:
     mandatory gene list defined in cooperation with the “National Network Genomic Medicine (nNGM) Lung Cancer”
   • C. NGS-Panels (Coverage > 1 MB):
     mandatory gene list in cooperation with the  “German Network for Personalized Medicine (DNPM)”
      

2. different EQA subschemes for fusions analyses:

   • A. NSCLC- specific NGS panels:
     mandatory fusion list defined in cooperation with the  “National Network Genomic Medicine (nNGM) Lung Cancer”
   • B. NGS-RNA panels for fusions:
     therapy-relevant fusions across entities 
      

3. Variant interpretation subscheme (dry-lab) 

   • Evaluation of bioinformatic analysis pipelines and interpretation of variants (without wet-lab, only dry-lab)  
      

All subschemes can be booked idependently and additional information will follow soon. 

In case of questions please contact:
Dr. rer. nat. Katharina Ilm (ilm@quip.eu; +49 30 921 0717 25)